Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I agree not right to treat shareholders with such disrespect.Who do they think they are .We invested when we thought they were close to market,but this was untrue just pump that was not controlled or denied by management Time for an update this is beyond acceptable. OWCP say something ,you now have a captured audience as 90% underwater.No news available just a slow bleed down.
purchased more shares today
thanks Gary ,I like the company just frustrated,down 40k
till owcp has news ,this investment is going side ways .You can hope wish and act like something might happen ,your only kidding yourself and others .this stock has dropped due to lack of information and development . owcp will not move till something happens .When it does you will have time to invest so shut up and wait.
.17 cents only bag holders left
great stuff thanks for DD
wont go below .17 bc of all the bag holders
play on words but u missed it .invested 2 years ago previous to run up,signed into hub later. OWCP has had time to research and produce medical marijuana ,inmy opinion ,i could have invested in bonds market or municipal bonds if I wanted to wait 2 years .The point is investors are stuck and we see other marijuana markets increasing.The communication style ,getting in lawsuit with employees and other delays have cost this company dearly.No one cares or is willing to invest in 2-4 years to get their money back.If I sound disappointed I,am with myself and others. Now I,m stuck in the mud ,other options" CBD"look much better to invest in. Good luck to all I will be here in the end .I will not average down lost faith any money I have will go somewhere else. jmo
stuck in mud ,lots of excitement in CBD oil and Canada.no fun here waiting and waiting .cant take large loss .stuck in the mud.SUCKS OWCP do something
what a disaster owcp is.Did they really think they can move at a snails pace and not have big pharma out play them. They should sell what they have and move on to something else.By the time they produce anything it will be obsolete.
absolutely anemic,a pure waste of money.SAD
owcp is one big joke LOL
who is selling owcp at this price.????
IG pulled owcp into the gutter.now he is here,be careful .
2 years later and down 90%.Pump and Dump
when is the qtr due? thanks
Typical Israeli pump and dump,they have a long history of this behavior .Rep Collins NY same thing, arrested for insider trading and yes he has a lot to loose with a big reputation .SAD we were all taken by OWCP.
see u in 2019.so down will take forever to recover
This company is toast.I,m down 90% nothing left to do but ride into the ground.Fraud from the start please don,t tell me about reputations .Bigger companies had fraud and theft than OWCP,and those involved will tell you they did,nt know ,not involved ,please.LOL.Who is going to invest in OWCP? they cant keep a deadline ,or keep an eye on people they hire.SAD
reputations mean nothing in a fraud.The letter hurt all of us ,what the f are they thinking.IDIOTS
read previous post letter to shareholders
tailsAdd To WatchlistCompareSet AlertTrade
Back to News
OWC Pharmaceutical Research Corp Letter to Shareholders
5 minutes agoPR Newswire
Related Investments
OWC Pharmaceutical Research Corp
Last 3 Months
RAMAT GAN, Israel, July 24, 2018 /PRNewswire/ --
OWC Pharmaceutical Research Corp. (OTCQB: OWCP), a developer of cannabinoid-based therapies targeting a variety of different medical conditions and disorders, today issued a letter to shareholders.
(Logo: http://mma.prnewswire.com/media/458036/OWC_Logo.jpg )
To our Shareholders,
The last period has been an important time for re-assessing our corporate strategy, consolidating our company and strengthening our abilities to execute our strategy. We believe that the strategic re-assessment that we have carried out over the last few months will be critical to our success.
The field in which we operate is increasingly crowded with unproven products. We believe that the companies that will succeed in such a market, will be the ones which have invested their resources in providing validated proof of efficacy and safety for their products. In the past, we have spoken of "market ready" products. This definition related to formulated products which were potentially marketable without the validation that I have eluded to above. We have made the decision that we do not want to compete in this undifferentiated market. Whilst in the short term, this will delay our commercial development, in the long term, this should be strongly value generating for our company and our shareholders.
In order to undertake this positioning, it was important to strengthen our company financially. In May, we announced the closing of the largest funding in the history of our company - a convertible preferred stock offering for US $5 million to an institutional investor. This funding will provide us with the runway to carry out our planned clinical programs. With respect to strengthening our team, we announced the recruitment of Dr. Oron Yacoby Zeevi, formerly CSO at Neuroderm, as our Chief Scientific Officer in February and we are currently planning additional senior personnel additions to increase our capabilities in clinical development and testing.
In December 2017, we announced that we had received a new permit from the Israeli Medical Cannabis Agency (IMCA) to proceed with safety studies for our cannabis soluble tablet delivery system. We subsequently received Institutional Review Board (IRB) approval from the Sourasky Medical Center in Tel Aviv and from the central Israeli Review Board to conduct these studies. In parallel, we announced the completion of the pre-clinical development of our next generation, orally-disintegrating tablet, the subject of the safety studies described above, and the initiation of these studies is now imminent. This tablet is intended to be a replacement for smoking cannabis in chronic pain syndromes. We also announced late in June that we had completed the first stage of the safety study of our cannabis cream. This initial stage comprised the single dosing of healthy volunteers. We are now waiting final volunteer license approval to initiate the second part of this trial, which comprises the twice daily dosing of healthy volunteers for 6 weeks.
With respect to our timeline going forward, key events till the end of this year include the following:
Completion of the cannabis cream safety study - Q4 2018
Initiation of the Oral Disintegrating Tablet safety study - Q4 2018
Completion of the Nasal Spray animal safety, pharmaco-kinetics and pharmaco-dynamics studies - Q4 2018
Whilst we understand that investors are keen to receive news flow, our clinical programs are complex to initiate in that they require multiple levels of approval from different authorities and the studies themselves are time consuming. These clinical programs are however key to our strategy and our positioning as a company dedicated to the pharmaceutical development of cannabis-based products to meet patients' needs.
On the commercial front, we have continued our business development activities in key future markets for our products. We will announce more specific developments in this area as soon as definitive agreements have been finalized.
The funding that we have obtained provides us with the resources to carry out our research and development programs and to continue our corporate and commercial development. We look forward to updating you on our progress in the coming months.
Yours sincerely,
Dr. Stanley Hirsch,
Chairman of the Board
About OWC Pharmaceutical Research Corp.
OWC Pharmaceutical Research Corp., through its wholly-owned Israeli subsidiary, One World Cannabis Ltd., (collectively 'OWC' or the 'Company') conducts medical research and clinical trials to develop cannabis-based pharmaceuticals and treatments for conditions including multiple myeloma, psoriasis, fibromyalgia, PTSD, and migraines.
OWCP is also developing unique delivery systems for the effective delivery and dosage of medical cannabis. All OWCP research is conducted at leading Israeli hospitals and scientific institutions and led by internationally renowned investigators. The Company's Research Division is focused on pursuing clinical trials evaluating the effectiveness of cannabinoids and cannabis-based products for the treatment of various medical conditions, while its Consulting Division is dedicated to helping governments and companies navigate complex international cannabis regulatory frameworks.
Contact:
3 million shares sold at 6k and the pp went down 10%????
https://www.nj.com/marijuana/2018/07/nj_just_effectively_decriminalized_weed_possession.html.who is elling at his price,now 98% investors loosing $$
Local police need to take the first step.MEMO from CHIEF of DEPARTMENT,we will show the way to prohibit personal use of phone in the police car.Then and only then will enforcement and fines be enforced.The administrator " chief" will monitor and police will enforce as they will be leading by example.Save Lives Please.
no happy hour for you.lost weeks gains in one day.
bag holders left cant afford to sell for huge loss in owcp
Facts are 99% of us are losing money.why? we invested in a Israel company several who have a long history of fraud pump dump and deceit.People on this site do a good job of investigating and research,however owcp is inept and doing their best to not let anyone know what is going on.We now are at a new yearly low ,with no bottom in site.How can you trust management ,were is the letter promised ,were is the excuse why the letter is delayed.Not the kind of people I want to make excuses for.
DISGUSTED with owcp! will not invest another penny or inform anyone.They had a proven pump and dump on their team.Now we wait 2 years for real development and research. Biggest MISTAKE you can invest in.Wait for proof of progress.When will the bleeding stop????
something is wrong here,WTF is going on????
No research is available for OWC Pharmaceutical Research Corp at this time
There is no hope left, owcp has extinguished everything ,let it go down to 0 and end it.They suck ,been here for too long waiting for nothing,lost over 85% of original investment.All BS ,stay in big companies and grow your investments the right way .Will check whats left of my investment in 2 years .
death by a thousand cuts.near year low
SB said july 4th .if u cant take him at his word ,where I come from he is a loser. sell everything
when ever I post owcp is a s--t show it communicates
my thoughts also.this could be the last straw if this expectation is BS. My money is locked up in this company for over a 1.5 years.I hope and pray we have some positive movement in the price soon.
why is it red? with all this good news
how will this work with uber or other taxis if they cant see the screen.????
No research is available for OWC Pharmaceutical Research Corp at this time